Funding
Turn ideas into impact
Show Me
Due: November 5, 2026
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-255
Due: November 13, 2026
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
US $1,050,000
Type
Grant
Source
Federal
Opp Number
PAR-25-270
Due: November 13, 2026
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-271
Due: November 13, 2026
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
US $350,000
Type
Grant
Source
Federal
Opp Number
PAR-25-269
Due: November 13, 2026
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
US $750,000
Type
Grant
Source
Federal
Opp Number
PAR-24-089
Due: November 16, 2026
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
US $50,000
Type
Grant
Source
Federal
Opp Number
PAR-25-370
Due: November 16, 2026
Major Research Instrumentation Program
US $100,000 – $4,000,000
Type
Grant
Source
Federal
Opp Number
23-519
Due: November 17, 2026
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-274
Due: November 17, 2026
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-268
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?